BRIOPTA Trademark

Trademark Overview

On Monday, March 26, 2012, a trademark application was filed for BRIOPTA with the United States Patent and Trademark Office. The USPTO has given the BRIOPTA trademark a serial number of 79116092. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Saturday, March 26, 2022. This trademark is owned by H. Lundbeck A/S. The BRIOPTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation and substances for the prevention and treatment of disorders and diseases in or affecting the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease, depression, psychosis, anxiety, epilepsy, sclerosis, porphyries, Huntington's disease, insomnia, Parkinson disease, schizophrenia, bipolar disorder, oncology, pain, alcoholism and dependency; diagnostic preparations, substances, reagents and agents for medical purposes
briopta

General Information

Serial Number79116092
Word MarkBRIOPTA
Filing DateMonday, March 26, 2012
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSaturday, March 26, 2022
Registration Number4336800
Registration DateTuesday, May 21, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 5, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparation and substances for the prevention and treatment of disorders and diseases in or affecting the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease, depression, psychosis, anxiety, epilepsy, sclerosis, porphyries, Huntington's disease, insomnia, Parkinson disease, schizophrenia, bipolar disorder, oncology, pain, alcoholism and dependency; diagnostic preparations, substances, reagents and agents for medical purposes
Translation of Words in MarkThe wording "BRIOPTA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 27, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameH. Lundbeck A/S
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDK
Party NameH. Lundbeck A/S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDK
Party NameH. Lundbeck A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDK

Trademark Events

Event DateEvent Description
Monday, October 24, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, October 24, 2022DEATH OF INTERNATIONAL REGISTRATION
Saturday, October 24, 2020TOTAL INVALIDATION PROCESSED BY THE IB
Friday, September 25, 2020TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, September 25, 2020INVALIDATION PROCESSED
Thursday, August 27, 2020TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, December 27, 2019CANCELLED SECTION 71
Monday, May 21, 2018COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, June 12, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 12, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, September 15, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, August 23, 2013FINAL DISPOSITION NOTICE SENT TO IB
Thursday, August 22, 2013FINAL DISPOSITION PROCESSED
Wednesday, August 21, 2013FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 21, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, April 9, 2013NOTIFICATION PROCESSED BY IB
Tuesday, March 5, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 5, 2013PUBLISHED FOR OPPOSITION
Wednesday, February 13, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 13, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 13, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 25, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, January 24, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 22, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 22, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 15, 2013ASSIGNED TO LIE
Sunday, January 13, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, September 23, 2012REFUSAL PROCESSED BY IB
Wednesday, September 5, 2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, September 4, 2012REFUSAL PROCESSED BY MPU
Tuesday, September 4, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 4, 2012APPLICATION FILING RECEIPT MAILED
Monday, September 3, 2012NON-FINAL ACTION WRITTEN
Wednesday, August 29, 2012ASSIGNED TO EXAMINER
Wednesday, August 29, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 28, 2012LIMITATION FROM ORIGINAL APPLICATION ENTERED
Monday, August 27, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

briopta substances pharmaceutical preparations nervous system disease central treatment prevention disorders